Newbury Park, CA, United States of America

Adriano Bauer

This inventor holds 1 USPTO granted patent and 4 published patent applications. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adriano Bauer: Innovator in Macrocyclic Compounds

Introduction

Adriano Bauer is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of macrocyclic compounds. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.

Latest Patents

Adriano Bauer holds a patent for "Macrocyclic compounds and methods of use." This patent provides compounds that are useful for the inhibition of various KRAS mutations, including G12D, G12V, G12A, G12S, G13D, Q61H, Q61L, and G12C. The compounds are described by a general Formula I′, with specific variables defined within the patent. Additionally, the disclosure includes pharmaceutical compositions that incorporate these compounds, emphasizing their potential applications in cancer treatment.

Career Highlights

Throughout his career, Adriano Bauer has demonstrated a strong focus on innovation in the pharmaceutical industry. His research has led to the development of compounds that could significantly impact cancer therapies. With 1 patent to his name, he continues to contribute to the scientific community through his inventive work.

Collaborations

Adriano has collaborated with esteemed colleagues, including Wei Zhao and Michael M Yamano. These partnerships have enhanced his research efforts and contributed to the successful development of his patented compounds.

Conclusion

Adriano Bauer is a dedicated inventor whose work in macrocyclic compounds holds promise for advancing cancer treatment. His innovative approach and collaborative spirit exemplify the essence of modern scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…